Home Title Index Topic Index Sources Directory News Releases Sources Calendar

Anavex appoints Dr. Jeffrey Cummings to its Scientific Advisory Board
Sources News Release

http://www.sources.com/Releases/NR1185.htm

Publisher:  Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written:  01/03/2011
Year Published:  2011  
Resource Type:  Article

Anavex Life Sciences Corp. has announced the appointment of Dr. Jeffrey Cummings to the Scientific Advisory Board as a clinical expert. The Scientific Advisory Board works closely with the company to support development of the Anavex product pipeline

Abstract:  Hoboken, NJ – March 1, 2011 -- Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today announced the appointment of Dr. Jeffrey Cummings to the Scientific Advisory Board as a clinical expert. The Scientific Advisory Board works closely with the company to support development of the Anavex product pipeline, including its lead compound ANAVEX 2-73, which is being studied for Alzheimer’s disease and is scheduled to enter Phase I clinical trials shortly. Dr. Cummings is the third clinical expert...
To read the full release go to http://www.sources.com/Releases/NR1185.htm

Topics


Sources-journalists use the sources website to find you


AlterLinks
c/o Sources


© 2023.